Ingemar Turesson

12PUBLICATIONS
15CO-AUTHORS
Social epidemiologyForensic evaluation, inference and statisticsMedical mycologyTe mātai huingaira o te Māori (Māori genomics)Medical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 23, 2025
Income and education affect prognosis and treatment in symptomatic myeloma : A population-based study on 8672 multiple myeloma patients diagnosed 2008-2021 from the Swedish myeloma registry.

Gunnar Larfors, Kristina Carlson, Christopher Day

|Sep 13, 2021
Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries.

Cecilie Hveding Blimark, Annette Juul Vangsted, Tobias W Klausen

|May 09, 2021
Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma.

Gudbjorg Jonsdottir, Magnus Björkholm, Ingemar Turesson

|Apr 11, 2021
Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population-based cohort study.

Saemundur Rögnvaldsson, Thor Aspelund, Sigrún Thorsteinsdóttir

|Feb 10, 2021
Comorbidities in multiple myeloma and implications on survival: A population-based study.

Ingigerður S Sverrisdóttir, Sölvi Rögnvaldsson, Sigrún Thorsteinsdottir

|Dec 09, 2020
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance.

Theodóra Rún Baldursdóttir, Þorvarður Jón Löve, Gauti Kjartan Gíslason

Pageof 2

Frequent Collaborators

5 joint publications

Sigurður Yngvi Kristinsson

3 joint publications

Sigrún Þorsteinsdóttir

2 joint publications

Ingigerður Sólveig Sverrisdóttir

2 joint publications

Vilhjálmur Steingrímsson